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ABSTRACT: A novel chemoenzymatic approach for the
synthesis of disialyl tetrasaccharide epitopes found as the
terminal oligosaccharides of GD1α, GT1aα, and GQ1bα is
described. It relies on chemical manipulation of enzymati-
cally generated trisaccharides as conformationally con-
strained acceptors for regioselective enzymatic α2−6-
sialylation. This strategy provides a new route for easy
access to disialyl tetrasaccharide epitopes and their
derivatives.
Sialic acids are common terminal residues on the glycanchains of various cell-surface glycoproteins and glycolipids.
These unique nine-carbon monosaccharides on the outermost
position of cell-surface glycoconjugates play important roles in
many physiological and pathological processes.1 For example,
the disialyl tetrasaccharide 1α (Figure 1) with an α
configuration at the reducing end is found in the O-glycans
of glycophorin (a major erythrocyte membrane glycoprotein),2
mucin MUC II,3 and erythropoietin (EPO).4 The disialyl
tetrasaccharide 1β with a β configuration at the reducing end is
an essential component of gangliosides GD1α, GT1aα, and
GQ1bα5 and the minimal binding epitope for high-affinity
myelin-associated glycoprotein (MAG, Siglic-4) ligands6
(Figure 1). Although the exact mechanism of the MAG−
ganglioside interaction is not well-understood, the axon
regeneration inhibited by MAG can be completely reversed
by sialidase treatment, suggesting that sialic acid in gangliosides
plays an essential role in high-affinity binding between MAG
and gangliodes.7 Structure−activity relationship (SAR) studies
have revealed that the terminal disialyl tetrasaccharide 1β of
GQ1bα shows superior binding to MAG compared with the
terminal trisaccharide epitope without the internal α2−6-linked
sialic acid on GalNAc, which is present in GM1b, GD1a, and
GT1b.5,6d Tetrasaccharide 1β has been considered as a leading
compound for the development of potent glycan inhibitors of
MAG to enhance axon regeneration for the injured adult
mammalian central nervous system.7
In order to study the functions of these widely distributed
disialyl tetrasaccharides at the molecular level and evaluate their
therapeutic potential, it is of great interest to develop an
efficient and practical synthetic approach for these tetrasac-
charides and their derivatives. Unfortunately, despite great
progress over the last two decades, the chemical synthesis of
sialic acid-containing complex structures is still challenging.8
Several elegant chemical synthetic methods of these disialyl
tetrasaccharides and related structures have been reported,4,9
but they are quite lengthy and time-consuming and require
tedious protecting-group manipulations. Alternatively, enzy-
matic synthesis using glycosyltransferases proceeds regio- and
stereoselectively without protection. Two different sialyltrans-
ferases, α2−3-sialyltransferase and α2−6-sialyltransferase, are
required to introduce two N-acetylneuraminic acid (Neu5Ac)
groups at C6 and C3′ of the Galβ1−3GalNAc disaccharide
core, respectively (Figure 1). To date, only a few recombinant
N-acetylgalactosamine α2−6-sialyltransferases (ST6GalNAc)
from mammalian sources have been employed in the synthesis
of the Neu5Acα2−6GalNAc sequence.10 A recombinant α2−6-
sialyltransferase from chicken (chST6GalNAc I) and a
recombinant α2−3-sialyltransferase from porcine (pST3Gal I)
have been successfully utilized for enzymatic production of
disialyl TF-antigen.10a However, a major problem encountered
in these processes is the low expression level of mammalian
sialyltransferases.10,11 To circumvent this issue with the use of
mammalian sialyltransferases, we herein report a chemo-
enzymatic approach for the synthesis of disialyl tetrasaccharide
epitopes and their derivatives through regioselective sialylation
of conformation-constrained trisaccharide acceptors by utilizing
a bacterial α2−6-sialyltransferase from Photobacterium damselae
(Pd2,6ST).12
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Figure 1. Naturally occurring disialyl tetrasaccharide epitopes.
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In contrast to mammalian sialyltransferases, several bacterial
sialyltransferases can be produced in sufficient amounts in
convenient bacterial expression systems and have remarkable
activities and promiscuous substrate specificities.11a,13 Several
bacterial sialyltransferases have been successfully employed in
highly efficient one-pot multienzyme (OPME) sialylation
systems for chemoenzymatic syntheses of various naturally
occurring and non-natural α2−3-, α2−6-, and α2−8-linked
sialosides.12,14 Our previous work showed that both terminal
Gal and GalNAc can be recognized by Pd2,6ST to form
Neu5Acα2−6Gal and Neu5Acα2−6GalNAc, respectively.14b
Structures containing both Gal and GalNAc such as Galβ1−
3GalNAc, however, have not been tested as acceptor substrates
for Pd2,6ST. When disaccharide Galβ1−3GalNAcβProAzide
(2)15 was used as an acceptor for Pd2,6ST and a varying
amount of Neu5Ac was used as the donor precursor, Pd2,6ST
was able to add Neu5Ac at both C6−OH of the internal
GalNAc and C6′−OH of the terminal Gal. A mixture of
monosialyl trisaccharides 3 and 4 and disialyl tetrasaccharide 5
was obtained, and the relative amount of 5 increased as the
amount of Neu5Ac used increased. When 1.0 equiv of Neu5Ac
was used, the yields of monosialyl trisaccharide 3 with Neu5Ac
α2−6-linked to the internal GalNAc, monosialyl trisaccharide 4
with Neu5Ac α2−6-linked to the terminal Gal, and disialyl
tetrasaccharide 5 were 34%, 32%, and 13%, respectively
(Scheme 1). The products can be easily separated from each
other by silica gel flash chromatography.
Both monosialyl trisaccharides 3 and 4 were then used as
acceptors for enzymatic sialylation using a recombinant
Pasteurella multocida α2−3-sialyltransferase (PmST1)14b to
introduce another Neu5Ac at the C3′ position on the Gal
(Scheme 2). PmST1-catalyzed α2−3-sialylation of monosialyl
trisaccharide 3 formed the desired disialyl tetrasaccharide 6 in
95% yield. In contrast, trisaccharide 4 was not a suitable
acceptor for PmST1, and no tetrasaccharide 7 was detected
under the same conditions. These results are consistent with
our previous findings16 and the observations from a recent
report by the Paulson group.17
The desired disialyl tetrasaccharide 6 can also be prepared by
an alternative two-step procedure with one-pot two-enzyme
α2−3-sialylation of disaccharide 2 to form α2−3-sialoside 814b
followed by one-pot two-enzyme α2−6-sialylation (Scheme 3).
However, α2−6-sialylation of 8 by Pd2,6ST led to the
production of a mixture of disialyl tetrasaccharides 6 and 7
and trisialyl pentasaccharide 9. Compounds 6 and 7 were
readily purified from the reaction mixture and from compound
9 as a mixture, but further separation proved to be challenging.
Quite interestingly, close examination of the NMR spectrum of
the mixture of 6 and 7 in comparison with that of the reference
pure tetrasaccharide 6 prepared by the previous two-step
procedure (Scheme 2) indicated that Pd2,6ST preferred to add
a Neu5Ac to the Gal instead of the GalNAc in monosialyl
trisaccharide 8 to produce the non-natural structure 7. A 29:71
ratio was observed for compound 6 to compound 7 as shown
by 1H NMR spectroscopy [see the Supporting Information
(SI) for details].
Previously, Boons and co-workers showed that conforma-
tion-constrained preorganized acceptor substrates can enhance
the reaction efficiency of sialyltransferase-catalyzed reactions.18
More recently, Withers and co-workers reported that the
substrate promiscuity of a given glycosyltransferase can be
expanded through substrate engineering.19 It is unclear why
Pd2,6ST regioselectively introduced Neu5Ac at the C6′
position of the Gal in trisaccharide acceptor 8 but showed no
Scheme 1. One-Pot Two-Enzyme α2−6-Sialylation of
Galacto-N-biose 2a
aReagents and conditions: (a) Neu5Ac (1.0 equiv), CTP (1.0 equiv),
Mg2+, Tris-HCl buffer (pH 8.5), NmCSS, Pd2,6ST, 37 °C, 2 h. Yields:
34% for 3; 32% for 4; 13% for 5.
Scheme 2. One-Pot Two-Enzyme α2−3-Sialylation of
Trisaccharides 3 and 4a
aReagents and conditions: (a) Neu5Ac (2.0 equiv), CTP (2.0 equiv),
Mg2+, Tris-HCl buffer (pH 8.5), NmCSS, PmST1, 37 °C, 1 h, 95%
yield for 6.
Scheme 3. One-Pot Two-Enzyme α2−3-Sialylation of
Disaccharide 2 Followed by One-Pot Two-Enzyme α2−6-
Sialylation of Trisaccharide 8a
aReagents and conditions: (a) Neu5Ac (1.2 equiv), CTP (1.2 equiv),
Mg2+, Tris-HCl buffer (pH 8.5), NmCSS, PmST1, 37 °C, 1 h; (b)
Neu5Ac (1.0 equiv), CTP (1.2 equiv), Mg2+, Tris-HCl buffer (pH
8.5), NmCSS, Pd2,6ST, 37 °C, 2 h. Yields: 63% for 6 and 7 (6:7 =
29:71 based on 1H NMR analysis); 9% for 9.
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preference toward the Gal or the GalNAc in the disaccharide
acceptor 2. Nevertheless, these results indicate that the C6′
hydroxyl group is more accessible than the C6 hydroxyl group
on trisaccharide acceptor 8 for Pd2,6ST and that the acceptor
substrate modification (with or without Neu5Ac at the C3′
position of disaccharide 2) can dramatically affect the reaction
outcome. On the basis of these phenomena, we hypothesized
that reversed regioselectivity could be achieved if the access to
the C6′ hydroxyl group is hindered.
To test our hypothesis, trisaccharide 8 was converted to
trisaccharide lactone 10 (Scheme 4) to constrain the
conformation of the Gal in the trisaccharide. The formation
of lactone 10 was achieved by acetylation and simultaneous
lactonization of trisaccharide 8 in the presence of acetic
anhydride and pyridine at 0 °C for 12 h followed by removal of
all of the O-acetyl groups from the resulting crude product
under the Zempleń conditions to produce trisaccharide lactone
10. Lactone formation is a common phenomenon in the
chemical synthesis of Neu5Acα2−3Gal and oligosialic acid-
containing structures under acidic conditions or during the
peracetylation step.20 The formation of the 1,4-lactone between
the C1″ carboxyl group of Neu5Ac and the C4′ hydroxyl group
of Gal during acetylation was confirmed by 1H, 13C, and 2D
NMR spectroscopies, which showed long-range connectivity
between the lactone CO at 165.98 ppm and the downfield
peak of Gal H4 at 5.24 ppm (see the SI for details).
Trisaccharide lactone 10 was then used as an acceptor for one-
pot two-enzyme α2−6-sialylation. The pH of the reaction was
controlled at 7.0 to allow good enzymatic activity and to
prevent spontaneous hydrolysis of the lactone at higher pH. To
our delight, lactone 10 was stable under the reaction conditions
used, and the reaction was completed in 2 h to produce disialyl
tetrasaccharide lactone 11 in 86% yield. Saponification of 11
produced disialyl tetrasaccharide 6 as the only product in 98%
yield (Scheme 4). The 13C NMR spectrum (Figure 2c) was
identical to that of the tetrasaccharide 6 prepared by the
previous two-step procedure (Figure 2b). 13C NMR analysis
also revealed that the minor regioisomer in the unseparated
mixture of 6 and 7 obtained from random sialylation of
trisaccharide 8 (Figure 2a) was identical to tetrasaccharide 6, as
indicated by the three peaks at 173.9, 104.6, and 99.6 ppm.
Previous SAR studies of MAG and disialyl tetrasaccharide
epitopes have demonstrated that the modification of Neu5Ac
by introducing hydrophobic substituents at the C9 position in
the Neu5Acα2−3GalNAc sequence can significantly increase
the binding affinity of the glycan and MAG.7 Encouraged by
these results, we carried out the chemoenzymatic synthesis of
disialyl tetrasaccharide epitope 15 containing the non-natural
sialic acid 9-N3-Neu5Ac α2−3-linked to the Gal (Scheme 5)
using the efficient lactone method described above. To our
delight, a similar high efficiency was achieved for the
chemoenzymatic synthesis of disialyl tetrasaccharide 15
(Scheme 5). The 9-N3 group in compound 15 can be used
as a chemical handle for easy derivatization.7
The general applicability of the method was further explored
by sialylation of trisaccharides containing a different sialic acid
form or a different internal galactoside. As shown in Scheme 6,
an α2−3-linked trisaccharide containing N-glycolylneuraminic
acid (Neu5Gc), a nonhuman sialic acid form with an additional
hydroxyl group at C5−NHAc, was also compatible with the
regioselective sialylation approach, producing disialyl tetrasac-
charide 19 as the only product via lactone intermediates.
Furthermore, α2−3-linked sialyl galactoside Neu5Acα2−
Scheme 4. Regioselective Sialylation of Trisaccharide
Lactone 10a
aReagents and conditions: (a) Ac2O, pyridine, 0 °C, 12 h; (b)
NaOMe, MeOH, 59% for two steps; (c) CMP-Neu5Ac (2.0 equiv),
Tris-HCl buffer (pH 7.0), Pd2,6ST, 37 °C, 2 h, 86%; (d) 1 M NaOH,
3 h, 98%.
Figure 2. Overlay of a selected region of the 13C NMR spectra of (a) a
mixture of 6 and 7 obtained from α2−6-sialylation of trisaccharide 8,
(b) tetrasaccharide 6 obtained from α2−3-sialylation of trisaccharide
3, and (c) tetrasaccharide 6 obtained from α2−6-sialylation of
trisaccharide lactone 10 followed by saponification.
Scheme 5. Regioselective Chemoenzymatic Synthesis of
Tetrasaccharide 15 via Lactone Intermediatesa
aReagents and conditions: (a) Ac2O, pyridine, 0 °C, 12 h; (b)
NaOMe, MeOH, 55% for two steps. (c) CMP-Neu5Ac (1.5 equiv),
Tris-HCl buffer (pH 7.0), Pd2,6ST, 2 h, 89%; (d) 1 M NaOH, 3 h,
96%.
Scheme 6. Regioselective Chemoenzymatic Synthesis of
Tetrasaccharide 19 via Lactone Intermediatesa
aReagents and conditions: (a) Ac2O, pyridine, 0 °C, 12 h; (b)
NaOMe, MeOH, 45% for two steps. (c) CMP-Neu5Ac (2.0 equiv),
Tris-HCl buffer (pH 7.0), Pd2,6ST, 2 h, 93%; (d) 1 M NaOH, 3 h,
98%.
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3Galβ1−3GalβSEt containing a different underlying disacchar-
ide was also a suitable substrate for lactone-mediated
regioselective sialylation, producing disialyl tetrasaccharide 24
as the only product (Scheme 7).
In summary, we have described a novel strategy for
chemoenzymatic synthesis of disialyl tetrasaccharide epitopes
containing natural and non-natural sialic acids using bacterial
sialyltransferase-catalyzed regioselective sialylation of confor-
mation-constrained acceptors. We have demonstrated that
unwanted acceptor substrate promiscuity of a given sialyl-
transferase can be prevented through “substrate engineering”.19
Similar strategies can be explored for the synthesis of other
carbohydrates using acceptor-substrate-promiscuous enzymes.
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Tris-HCl buffer (pH 7.0), Pd2,6ST, 2 h, 92%; (d) 1 M NaOH, 3 h,
98%.
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